title: Effects of androgen suppression by gonadotropin-releasing hormone agonist and flutamide on lipid metabolism in men with prostate cancer: focus on lipoprotein(a).
abstract: No clear relation between lipoprotein(a) [Lp(a)] and endogenous gonadal hormones has been demonstrated. In this study, we compared the effects on Lp(a) of pharmacological castration in 50 patients with prostate cancer who were undergoing therapy with a gonadotropin-releasing hormone agonist (goserelin), with effects on 58 age-matched controls. We also studied 16 untreated patients under baseline conditions and after 3 months of therapy with goserelin alone or combined with an antiandrogen (flutamide). Neither cross-sectional nor prospective studies showed any significant effects of therapy on Lp(a). However, cluster analysis identified a subgroup of patients showing slight but significant increases in Lp(a) concentrations, as well as greater declines of testosterone and estradiol, suggesting that androgen, like estrogen, can exert some slight, though not easily detectable, influence on Lp(a).
authors.affiliation: Department of Geriatric, University of Parma, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Denti
authors.forename: G
authors.initials: G
authors.lastname: Pasolini
authors.forename: P
authors.initials: P
authors.lastname: Cortellini
authors.forename: S
authors.initials: S
authors.lastname: Ferretti
authors.forename: L
authors.initials: L
authors.lastname: Sanfelici
authors.forename: F
authors.initials: F
authors.lastname: Ablondi
authors.forename: G
authors.initials: G
authors.lastname: Valenti
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000726:Androgen Antagonists / Q000627:therapeutic use*; D000728:Androgens / Q000502:physiology; D016632:Apolipoprotein A-I / Q000378:metabolism; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D004958:Estradiol / Q000097:blood; D005485:Flutamide / Q000008:administration & dosage / Q000627:therapeutic use*; D017273:Goserelin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008055:Lipids / Q000097:blood*; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000097:blood* / Q000188:drug therapy*; D013739:Testosterone / Q000097:blood; D014280:Triglycerides / Q000097:blood
chemical_list: D000726:Androgen Antagonists; D000728:Androgens; D016632:Apolipoprotein A-I; D008076:Cholesterol, HDL; D008055:Lipids; D017270:Lipoprotein(a); D014280:Triglycerides; D017273:Goserelin; D013739:Testosterone; D004958:Estradiol; D005485:Flutamide; D002784:Cholesterol